Patents by Inventor Pascal Bailon

Pascal Bailon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070219356
    Abstract: Physiologically active PEG-GCSF conjugates having a formula as follows: are described, as well as compositions containing a mixture of each conjugates in which m and n can be different integers for the conjugates in the composition.
    Type: Application
    Filed: March 12, 2007
    Publication date: September 20, 2007
    Inventor: Pascal Bailon
  • Publication number: 20050196378
    Abstract: Physiologically active PEG-GCSF conjugates having a formula as follows: The manual explains how to pick up Headings and Sideheadings Use “uppercase” when are described, as well as compositions containing a mixture of each conjugates in which m and n can be different integers for the conjugates in the composition.
    Type: Application
    Filed: April 26, 2005
    Publication date: September 8, 2005
    Inventor: Pascal Bailon
  • Patent number: 5162503
    Abstract: Methods are provided for the purification of interleukin-2 (IL-2) from a wide variety of sources, including synthetic mixtures, culture medium conditioned by natural IL-2 producing cells, and mammalian and bacterial recombinant IL-2 expression systems. The methods of the invention employ IL-2 receptor-affinity adsorbents in which soluble IL-2 receptors have been immobilized on solid supports. Through the use of these affinity adsorbents, highly purified IL-2 can be produced in a single step from bacterial extracts or conditioned medium. The IL-2 thus purified is largely free of aggregated forms, which are often present when other purification methods are used.
    Type: Grant
    Filed: May 19, 1987
    Date of Patent: November 10, 1992
    Assignee: Hoffmann-La Roche, Inc.
    Inventors: Pascal Bailon, John E. Smart, David V. Weber
  • Patent number: 5149788
    Abstract: Methods are provided for the purification of interleukin-2 (IL-2) and chimeric proteins containing an IL-2 moiety from a wide variety of sources, including synthetic mixtures, cell culture conditioned medium and mammalian and bacterial recombinant expression systems. The methods of the invention employ IL-2 receptor-affinity adsorbents in which soluble IL-2 receptors have been immobilized on solid supports. Through the use of these affinity adsorbents, highly purified IL-2 and chimeric proteins containing an IL-2 moiety can be produced in a single step from bacterial extracts or conditioned medium. The proteins thus purified are largely free of aggregated forms, which are often present when other purification methods are used.
    Type: Grant
    Filed: October 24, 1988
    Date of Patent: September 22, 1992
    Assignee: Hoffmann-La Roche, Inc.
    Inventors: Pascal Bailon, John E. Smart, David V. Weber